Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010956

Chief R&D Officer sold 10,484 shares at $3.00 ($31,452)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zalevsky Jonathan Chief R&D Officer 2023-02-16 Sale −10,484 $3.00 $31,452 303,179 D
Open-market sales · 10,484 sh · avg $3.00 · $31,452
Loading xslF345X03/doc4.xml…